Safety of maitake D-fraction in healthy patients: Assessment of common hematologic parameters

Alternative and Complementary Therapies

Volumn 10, Issue 4, 2004, Pages 228-230

  Glauco, Smadelli ^a   Jano, Freddo ^a   Paolo, Giordo ^a   Konno, Sensuke ^b  

^a New York Medical College ^*

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GRIFRON PRO; MAITAKE D FRACTION; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MEDICINAL PLANT; MUSHROOM; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 3943111686     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/1076280041580341     Document Type: Article

References (13)

1. Hishida I, Nanba H, Kuroda, H. Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (maitake). Chem Pharm Bull (Tokyo) 1988;36:1819-1827.
2. Adachi K, Nanba H, Kuroda H. Potentiation of host-mediated antitumor activity in mice by β-glucan obtained from Grifola frondosa (maitake). Chem Pharm Bull (Tokyo) 1987;5:262-270.
3. Mizuno T, Zhuang C. Maitake, Grifola frondosa: Pharmacological effects. Food Rev Int 1995;11:135-149.
4. Adachi K, Nanba H, Otsuka M. et al. Blood pressure-lowering activity present in the fruit body of Grifola frondosa. Chem Pharm Bull (Tokyo) 1988;36:1000-1006.
5. Kubo K, Aoki H, Nanba H. Anti-diabetic activity present in the fruit body of Grifola frondosa (maitake). Biol Pharm Bull 1994;17:1106-1110.
6. Kubo K, Nanba H. The effect of maitake mushrooms on liver and serum lipids. Altern Ther Health Med 1996;2:62-66.
7. Nakai R, Masui H, Horio H. et al. Effect of maitake (Grifola frondosa) water extract on inhibition of adipocyte conversion of C3H10T1/2B2C1 cells. J Nutr Sci Vitaminol (Tokyo) 1999;45:385-389.
8. Wu S, Zou D, Han SH. et al. Therapeutic effect of Grifola polysaccharides in chronic hepatitis B. International Symposium on Production and Products of Lentinus Mushroom, Programme and Abstracts. Qingyuan, China, November 1994.
9. National Cancer Institute, Developmental Therapeutics Program. Invitro anti-HIV drug screening results [F195001]. Bethesda: National Science Council, January 1992.
10. Fullerton SA, Samadi AA, Tortorelis DG. et al. Induction of apoptosis in human prostatic cancer cells with β-glucan (maitake mushroom polysaccharide). Mol Urol 2000;4:7-11.
11. Finkelstein MP, Aynehchi S., Samadi AA. et al. Chemosensitization of carmustine with maitake β-glucan on androgen-independent prostatic cancer cells: Involvement of glyoxalase I. J Altern Complement Med 2002;8:573-580.
12. Nanba H. Maitake D-fraction: Healing and preventive potential for cancer. J Orthomol Med 1997;12:43-49.
13. Maitake Products, Inc. Maitake D-fraction obtained IND for clinical study (corporate publication). Ridgefield Park, NJ: Maitake Products, Inc., February, 1998.